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Abstract 
We studied transport of non-transferrin ron into HeLa cells adapted for growth in defined medium, containing either 
5 Ixg/ml of iron-saturated transferrin (HeLa/Tf  cells) or 5 IxM ferric citrate (HeLa/Fe5 cells) as a source of iron. 
Employing 55Fe-ferric itrate, iron uptake by intact cells was compared with iron binding to isolated membranes. Uptake 
characteristics of both HeLa/Tf  and HeLa/Fe5 cells seemed to be similar: K m = 141xM and Vma x = 135pmol 
Fe/min/105 cells for HeLa/Tf,  K m =221xM and Vma x = 165pmol Fe/min/105 cells for HeLa/Fe5. Increasing 
concentrations (0.3-1.2 ixM) of 55Fe-ferric itrate, producing levels of free 55Fe which were independent of total Fe under 
the experimental conditions used, led to increased binding of 55Fe for both HeLa/Tf  and HeLa/Fe5 cells (1.08-8.03 nmol 
Fe/h/105 cells). This corresponds with the suggestion that iron was bound in the form of ferric citrate rather than in the 
form of free iron. Dissociation constants of Fe binding, K D = 0.61 IxM for HeLa/Tf  and K D = 1.53 txM for HeLa/Fe5, 
were obtained from competition experiments. We conclude that specific binding sites for ferric citrate are constitutively 
expressed in plasma membrane and that their expression does not require the induction by the presence of ferric citrate. The 
uptake of non-transferrin ron is realized in at least two steps. The first step is iron binding to the specific binding sites in 
plasma membrane. The binding does not represent a limiting step of the uptake. © 1998 Elsevier Science B.V. 
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1. Introduction 
Iron is transported by the serum glycoprotein 
transferrin in vertebrates. Animal cells acquire trans- 
ferrin-bound iron by receptor-mediated endocytosis 
* Corresponding author. Fax: +420-2-4713443; E-mail: 
kovar@biomed.cas.cz 
of transferrin-transferrin eceptor complex [1,2]. 
Transferrin-dependent iron transport is not the only 
pathway of iron uptake. Previous studies have docu- 
mented transferrin-independent iron uptake by cells 
both, in vivo [3-6] and in vitro [7-13]. HeLa cells 
were shown to take up ferric as well as ferrous iron 
from complexes with citrate, ascorbate and nitrilotri- 
acetate [10,14,15]. However, the mechanism of non- 
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transferrin iron transport has not been elucidated until 
now. 
There are several reasons to suppose that the pro- 
cess of non-transferrin iron uptake is of physiological 
significance. One of the reasons is connected with the 
possibility that tumor cells utilize non-transferrin iron 
uptake as an alternative pathway for iron acquisition 
[7,13]. In normal human plasma, only a small portion 
(ca. 1%) of total iron is bound to low-molecular- 
weight complexes, mainly to citrate [16]. However, 
significantly higher local concentrations of non-trans- 
ferrin iron caused by cell necroses and release of 
cytoplasmatic pools of iron are likely in the tumor 
microenvironment [8,17]. Moreover, the non-transfer- 
rin iron transport across the cell membrane could be 
analogous to the passage of iron from endocytic 
vesicles after its release from internalized transferrin 
[11]. It could also tell us something about internaliza- 
tion of other metals [10]. 
The present study deals with non-transferrin ron 
transport into HeLa cells. Iron uptake by the cells 
was compared with iron binding to isolated cell 
membranes. We found that there are specific binding 
sites for iron in plasma membrane. These binding 
sites are constitutively expressed. Binding to these 
sites is the first though not limiting step of non-trans- 
ferrin iron uptake. 
2. Materials and methods 
2.1. Cells and culture conditions 
A clone of the human cell line HeLa (cervical 
carcinoma), growing as a suspension culture, was 
obtained from A. Cvekl (Institute of Organic Chem- 
istry and Biochemistry, Prague, Czech Republic). 
HeLa/Tf  cells and HeLa/Fe5 cells are cells adapted 
for long-term growth in Tf medium and Fe5 medium, 
respectively. Tf medium comprises PFH medium, 
described previously [18], with 5p~g/ml of iron- 
saturated human transferrin instead of 500 ~M ferric 
citrate. Fe5 medium comprises PFH medium, con- 
taining only 5 ~M ferric citrate [19,20]. PFH medium 
is based on RPMI 1640 medium. Cells were cultured 
at 37°C in a humidified atmosphere of 5% CO 2 in 
air. 
2.2. Iron uptake measurement 
We employed a method derived from the method 
used by Inman and Wessling-Resnick [11]. Cells 
were harvested by low-speed centrifugation (10rain 
at 500 × g) and washed twice with the medium 
lacking transferrin or ferric citrate and used immedi- 
ately. The incubation performed at 37°C (4°C), in a 
final volume of 0.5 ml, was started by the addition of 
cells (0.2-0.3 X 10 6 cells) to the incubation medium. 
The incubation medium contained ferric citrate (final 
Fe concentration of 0.6-300 ~M including 0.6 p~M 
~SFe-ferric itrate as a tracer) at Fe :citrate molar 
ratio of 1 : 1.5. After the incubation period, the uptake 
was stopped immediately by rapid vacuum filtration 
of the incubation mixture on Whatman GFC fibre 
glass filters. Filters were washed thrice with 5 ml of 
ice-cold PBS. Radioactivity of the cells retained on 
the filters was measured by liquid scintillation in a 
Beckman LS 7800 counter. 
Values for iron uptake in the initial part of time 
dependence were supposed to be influenced by iron 
binding to the membrane sites. However, the satura- 
tion of the binding was found to be very rapid 
(1.5-3min) at 37°C. Therefore, the rate of the up- 
take, which was calculated from the approximately 
linear part of time-dependence curves (1.5-17rain) 
was not influenced significantly by the initial iron 
binding. Radioactivity associated with the cells after 
the incubation at 4°C, which was mainly related to 
the non-specific binding, represented only ca. 10- 
20% of the radioactivity associated with the cells 
after the incubation at 37°C for individual experi- 
ments. 
2.3. Preparation of membrane fraction 
Cells were harvested by low-speed centrifugation 
(10rain at 500 × g) and washed twice with the 
medium lacking transferrin or ferric citrate. Washed 
cells were resuspended in ice-cold PBS and homoge- 
nized with a Potter-Elvehjem glass homogenizer. 
The homogenate was centrifuged for 10min at 
700 × g. Supernatant was collected and centrifuged 
for 30 min at 60 000 × g. Supernatant was removed 
and the pellet was resuspended in ice-cold 25 mM 
HEPES buffer (pH 7.4) at a concentration corre- 
sponding to 10-20 × 10 6 cells/ml. Membranes were 
stored at -20°C no longer than 2 months. 
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2.4. Measurement of iron binding to cell membranes 
The binding of 55Fe to membrane fractions of 
Hela/Tf  and Hela/Fe5 cells incubated in increasing 
concentrations of 55Fe-ferric itrate (0.3-1.2 ~M) was 
measured as follows: the incubation was performed at 
25°C in a final volume of 0.5 ml. Membrane fraction 
corresponding to 2 × 10 6 cells was added to the 
incubation buffer (25 mM HEPES, pH 7.4) contain- 
ing the required amount of 55Fe-ferric citrate and 
incubated for l h. The competition between 55Fe 
binding from 55Fe-ferric citrate and cold Fe binding 
from increasing concentrations of ferric citrate in 
equilibrium was measured as follows: the incubation 
was again performed at 25°C in a final volume of 
0.5ml. Membrane fraction corresponding to 0.5 × 
106 cells was added to the incubation buffer (25 mM 
HEPES, pH 7.4) containing 55Fe-ferric citrate (final 
concentration f 0.6 p~M) plus the required amount of 
cold ferric citrate (10-9-10 -4 M) and incubated for 
30 min. The incubations were stopped by rapid vac- 
uum filtration of the incubation mixtures on What- 
man GFC fiber glass filters. Filters were washed 
thrice with 5 ml of ice-cold 5 mM HEPES. Radioac- 
tivity of membranes retained on filters was measured 
by a Beckman LS 7800 liquid scintillation counter. 
Acquired competition data were analyzed by non- 
linear regression employing the program ENZFIT- 
TER and using the equation B/Bm~ × = LnH/(ICso~H + 
L TM) [21,22], where n H is the Hill slope factor, 
B/Bm~ the fraction of occupied binding sites and L 
the concentration of radioligand (constant during the 
experiment). 
3.  Resu l ts  
3.1. Iron uptake by cells 
We studied iron accumulation from ferric citrate- 
containing medium by HeLa/Tf  cells (HeLa cells 
adapted for long-term growth in transferrin medium 
containing 5 p~g/ml of transferrin as a source of iron) 
and by HeLa/Fe5 cells (HeLa cells adapted for 
long-term growth in Fe5 medium containing 5IxM 
ferric citrate as a source of iron). 
The accumulation from 0.6-300 I~M ferric citrate 
increased more or less linearly during the first 1.5- 
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Fig. 1. Time dependence of iron uptake by HeLa/Tf cells at 
37°C incubated in various concentrations f ferric citrate: (0 )  - 
100p~M, (m) - 30p~M, (A )  - 18p~M, (v )  - 10p~M, (0 )  - 
5 .8~M,  (filled hexagon) - 3.4p~M, (O) - 1.6p~M and (n) - 
0.6 p~M. All ferric citrate concentrations contained 0.6 I~M 55Fe 
as a tracer. Each point represents the mean of two independent 
experiments. 
17 min for both HeLa/Tf  and HeLa/Fe5 cells (Figs. 
1 and 2). After 17 min, the values of accumulated 
iron by HeLa/Tf  cells were in the 0.038-4.600 nmol 
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Fig. 2. Time dependence of iron uptake by HeLa/Fe5 cells at 
37°C incubated in various concentrations f ferric citrate: (O) - 
300~M, (m) - 100~M, (A )  - 30~M,  (T )  - 10p~M, (0 )  - 
3.4 p~M, (filled hexagon) - 1.6 p~M and (O) - 0.6 ~M. All ferric 
citrate concentrations contained 0.6 ~M 55Fe as a tracer. Each 
point represents the mean of two independent xperiments. 
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Fig. 3. The effect of ferric citrate concentration the rate of Fe 
uptake by (A) HeLa/Tf and (B) HeLa/Fe5 cells. 55Fe-ferric 
citrate (0.6M) was used as a tracer. Rate values were calculated 
by linear regression from the linear part of time-dependence 
curves of iron uptake (see Figs. 1 and 2). 
Fe/105 cells range for extracellular 0.6-100 I~M fer- 
ric citrate. HeLa/Fe5 displayed values 0.029- 
8.368nmol Fe/105 cells for 0 .6 -300~M ferric cit- 
rate. 
Uptake values in the approximately inear part of 
the time-dependence urves (1.5-17min) were used 
to calculate the rate of iron uptake by a linear regres- 
sion. The rate of the uptake was plotted against ferric 
citrate concentration (Fig. 3(A) and (B)). We as- 
sessed K m and Vma x from the curves to be K m = 
141xM and Vma x = 135pmol Fe /min /105  cells for 
HeLa /T f  and K m = 221xM and Vma x = 165pmol 
Fe /min /105  cells for HeLa/Fe5 cells. Uptake char- 
acteristics of HeLa /T f  and HeLa/Fe5 seemed to be 
similar. 
Table 1 
55Fe binding to membrane fractions of HeLa/Tf and HeLa/Fe5 
cells incubated in various concentrations of 55Fe-ferric citrate 
Cell type 55Fe concentration Bound 5SFe a 
(txM) (nmol/105 cells) 
HeLa/Tf 0.3 1.08 
0.6 2.90 
1.2 5.78 
HeLa/Fe5 0.6 3.74 
1.2 8.03 
~After I h incubation at 25°C. Data are from one representative 
experiment. 
3.2. Iron binding to plasma membrane 
Our preliminary experiments showed that Fe bind- 
ing to membrane fractions of HeLa /T f  as well as of 
HeLa/Fe5 cells is a relatively rapid proces. The 
equilibrium at 25°C was reached within 10-15 min. 
At 4°C, the reaction was in equilibrium within I h. 
55Fe binding to the membranes increased with 
increasing concentration of 55Fe-ferric itrate for both 
HeLa /T f  and HeLa/Fe5 cells (Table 1). This corre- 
sponds with the suggestion that iron binds in the form 
of ferric citrate rather than in the form of free iron 
when considering the extremely high constant of 
complex stability of 10115 M-1 [23] and the 1.5-fold 
excess of citrate in the reaction (see Section 4). The 
binding to HeLa/Fe5 cells seems to be somewhat 
higher than the binding to HeLa/Tf .  
When membranes were incubated with 0.6 I~M 
55Fe-ferric citrate plus increasing concentrations of 
cold ferric citrate, the 55Fe binding decreased and 
reached total inhibition at 104M cold ferric citrate 
(Fig. 4(A) and (B)). The curves fitted best the model 
of one type of binding site. The Hill coefficient n u 
was found to be close to unity (1.01 for HeLa /T f  
and 1.09 for HeLa/Fe5).  This points strongly to the 
presence of only a single class of binding sites, or to 
the possibility that the contribution of other binding 
sites is not significant. The dissociation constant of 
Fe binding calculated from the ICs0 was K D = 
0.61 i-~M for HeLa /T f  cells and K o = 1.53 ~M for 
HeLa/Fe5 cells. K o for both, HeLa /T f  and 
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Fig. 4. Binding of 55Fe from 55Fe-ferric itrate (0.61xM) to 
membrane fractions of (A) HeLa/Tf and (B) HeLa/Fe5 cells in 
the presence of increasing concentrations (10-9 -10-4M)  of 
cold Fe (ferric citrate) at 25°C. Control represents 55Fe binding 
without he presence of cold Fe. Each point is the mean of two 
independent experiments representing 2-3 experimental values. 
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HeLa/Fe5 was in the range of concentrations corre- 
sponding to the specific binding. 
4. Discussion 
Simple equilibrium of ferric ions forming 1:1 
complex with citrate is given by a stability constant 
which is = 10115 M-~ [23]. Non-transferrin iron used 
in our study was in the form of ferric citrate with the 
molar ratio Fe:citrate of 1: 1.5. In the presence of 
1.5-fold excess citrate, most of the ferric iron is 
bound as the citrate complex. Only ca. 10 ~ M iron 
is present as free iron independently of the total iron 
concentration within the 10-3 -10-7M range (Fig. 
5). This means that a change of total ferric citrate 
concentration within the foregoing range does not 
affect the apparent concentration of free iron. If iron 
binds to the membrane as free iron, an increase in 
ferric citrate concentration within the mentioned range 
would not lead to increased iron binding. However, 
in our experiments increased levels of 55Fe-ferric 
citrate resulted in increased binding of 55Fe (see 
Table 1). Therefore, we can assume that iron binds to 
the membrane in the form of ferric citrate and, thus, 
we can assess K D of the binding by a competition 
experiment with cold ferric citrate. 
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Fig. 5. Dependence of free ferric iron concentration  total ferric 
citrate concentration for various molar atios Fe:citrate (1:0.1, 
0.9, 1.0, 1.1, 1.5, 5.0). Data were obtained by theoretical calcula- 
tions using an equation derived from the formula for the stability 
constant of the ferric citrate complex. 
A competition experiment with isolated mem- 
branes of HeLa/T f  (cells grown in a medium with 
5 txg/ml of transferrin) and HeLa/Fe5 (cells grown 
in a medium with 5 IxM of ferric citrate) showed total 
inhibition of 55Fe binding by increasing concentra- 
tions of cold ferric citrate (see Fig. 4). K D values 
correspond with a specific binding and the slope of 
the competition curve corresponds with binding to 
one type of binding site. For both HeLa/T f  and 
HeLa/Fe5 cells K D values are comparable (0.61 o~M 
and 1.53 IxM). This means that the binding sites for 
ferric citrate are, in general, constitutively expressed 
in plasma membrane and their expression does not 
require induction by the presence of ferric citrate. 
Such a suggestion is also supported by similar K m 
values (14 IxM and 22 ~M) for both HeLa/T f  and 
HeLa/Fe5. 
However, slightly increased Fe binding to 
HeLa/Fe5 membranes than to HeLa/T f  membranes 
(Table 1) seems to be reproducible. Such an increase 
could represent a certain degree of upregulation of 
the binding sites due to previous cultivation of 
HeLa/Fe5 cells in the presence of non-transferrin 
iron. 
If we compare K D and K m values for both 
HeLa/T f  and HeLa/Fe5 cells, K m values are 
roughly one order of magnitude higher than K D 
values. This means that specific non-transferrin iron 
uptake is carried out in at least two steps. The first 
step is iron binding to specific binding sites in plasma 
membrane. The binding does not represent a limiting 
step of the uptake. 
Melanotransferrin, known as p97 and structurally 
similar to serum transferrin [24], represents an obvi- 
ous candidate for a specific iron binding site in the 
plasma membrane of mammalian cells. Iron uptake 
by our HeLa cells represents a process with relatively 
low affinity (Km ca. 20 p,M) and high capacity (Vma x
ca. 1500 pmol /min/106 cells). Kennard et al. [25] 
found rather differing values (K m ca .  2 ~M, a capac- 
ity of ca. 1 pmol/min/106cel ls)  for p97 in CHO 
cells representing a process with higher affinity and 
much lower capacity. Our recent data shows that p97 
is expressed on HeLa cells. Treatment of the cells 
with phosphatidylinositol-specific phospholipase C
results in a dramatic decrease in cell surface p97 
which is not, however, accompanied with a relevant 
decrease of iron uptake (Kriegerbeckovfi and Kovfff, 
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manuscript under preparation). Therefore, it seems 
that p97 is not involved in non-transferrin iron uptake 
by HeLa cells. 
In conclusion, we can state that specific uptake of 
non-transferrin iron from ferric citrate by HeLa cells 
is achieved in at least two steps. The first step is 
binding of ferric citrate to specific binding sites in 
plasma membranes. The binding sites are expressed 
constitutively and the binding to the sites is not a 
limiting step of the uptake. However, the mechanism 
of iron transport across the membrane as well as the 
specific binding sites involved remain unknown. 
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